ASCO Education

Self-Evaluation: Apar Kishor Ganti, MD, Professor in the Department of Internal Medicine, Division of Oncology/Hematology, and Associate Director of Clinical Research at the Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, presents a self-evaluation question from an ASCO University course focusing on the treatment of an EGFR Mutation.  

Dr. Linh Alejandro, a clinical oncology pharmacist at the University of California, San Diego Health Systems discusses the approval of olaparib for germline BRCA-mutated metastatic breast cancer.

An interview with Dr. Christopher Flowers of Emory University School of Medicine on the ASCO/IDSA clinical practice guideline which provides updated recommendations on outpatient management of fever and neutropenia in patients with cancer. Read the full guideline at www.asco.org/supportive-care-guidelines

Shadia Jalal, MD, Assistant Professor of Clinical Medicine Department of Medicine Division of Hematology/Oncology Indiana University School of Medicine, presents a self-evaluation question from an ASCO University course focusing on the treatment of non-small cell lung cancers.

Dr. Rodrigo Munhoz, medical oncologist at Centro de Oncologia- Hospital Sírio-Libanês in Sao Paolo, Brazil, discusses recent advances in the adjuvant therapy for patients with high-risk melanoma

Alex Ganetsky, PharmD, BCOP, oncology clinical pharmacy specialist at the Hospital of the University of Pennsylvania in Philadelphia discusses the approval to blinatumomab (Blincyto, Amgen Inc.) for the treatment of adult and pediatric patients with B-cell precursor acute lymphoblastic leukemia (ALL) in first or second complete remission with minimal residual disease (MRD) greater than or equal to...

An interview with Dr. Bryan Schneider of the University of Michigan on the ASCO clinical practice guideline to increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy. Read the full guideline at  www.asco.org/supportive-care-guidelines  

Cindy Schwartz, MD, MPH, is an accomplished oncologist who brings 35 years of experience, passion and expertise in the areas of Hodgkin lymphoma, osteosarcoma and childhood cancer survivorship.

Dr. Carolyn Hendricks is a board certified medical oncologist specializing in breast cancer. She received her medical degree from Johns Hopkins University School of Medicine and has been in practice for more than 20 years. 

Dr. Larissa Nekhlyudov is a board-certified general internist and Medical Director of Primary Care Associates, Longwood. Dr. Nekhlyudov practiced internal medicine at Harvard Vanguard Medical Associates for over 15 years. In this episode she discusses the importance of effective communication between the primary care physician & oncologist for AYA patients diagnosed with cancer.

Dr. Suresh Ramalingam, professor of hematology and medical oncology at Emory University and Deputy Director at the Winship Cancer Institute of Emory University, presents a self-evaluation question on Clinical Trials: Informed Consent

Dr. Suresh Ramalingam, professor of hematology and medical oncology at Emory University and Deputy Director at the Winship Cancer Institute of Emory University, presents a self-evaluation question on clinical research methodologies, clinical trials, phase III.

Dr. Benjamin Levy, Clinical Director at the Johns Hopkins Sidney Kimmel Cancer Center at the Sibley Memorial Hospital in Washington, D.C., presents a self-evaluation questions on non-small cell lung cancer.

Dr. Shaheenah Dawood, consultant medical oncologist and lead of the oncology research program at the Comprehensive Cancer Center Mediclinic City Hospital in the United Arab Emirates, presents a self-evaluation question on the predictive and prognostic rule of pathological complete response attained in the treatment of breast cancer.

Dr. Aditya Bardia, attending physician at the Massachusetts General Hospital Cancer Center, presents a self-evaluation question on the treatment of metastatic breast cancer.

Dr. Gregory Riely, medical oncologist at Memorial Sloan Kettering Cancer Center in New York City, presents the ASCO Guideline update on Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer, published in the Journal of Clinical Oncology in August 2017.

Dr. Matthew Yurgelun, assistant professor of medicine at Harvard Medical School and gastrointestinal medical oncologist at the Dana Farber Gastrointestinal Cancer Center and Cancer Genetics and Prevention Program, presents information on the recently approved nivolumab for the treatment of patients 12 years and older with mismatch repair deficient and microsatellite instability high metastatic col...

Dr. Janice Dutcher, Associate Director of the Cancer Research Foundation of New York and medical oncology co-chair of the NCI Renal Cancer Task Force, presents a self-assessment question on the treatment of castrate-resistant metastatic prostate cancer.

Dr. Christina Wiedl, director of the pediatric and young adult stem cell transplant program at Virginia Commonwealth University, presents information on the recently approved drug in oncology, keytruda for relapsed and refractory classical Hodgkin lymphoma in pediatric and young adult patients.

Dr. Josh Lauring, Assistant Professor of Oncology at the Sidney Kimmel Cancer Center at John's Hopkins, presents the joint ASCO/AMP Guideline on Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in cancer, published in the Journal of Molecular Pathology in January 2017.

Dr. Ornob Roy, Urologist with Carolinas Healthcare Systems, presents the ASCO Guideline on Management of Small Renal Masses, originally published in the Journal of Clinical Oncology in January 2017.

Dr. Alok Khorana, medical oncologist and professor of medicine at the Cleveland Clinic, presents the recently published ASCO Guideline on potentially curable pancreatic cancer.

Dr. Philip Castle, Professor in the Department of Epidemiology and Population Health at Albert Einstein College of Medicine, presents the ASCO Guideline on Secondary Prevention of Cervical Cancer, originally published in the Journal of Clinic Oncology in October 2016.

Saro H. Armenian, D.O., MPH, pediatric hematologist/oncologist at City of Hope, presents the ASCO Guideline on prevention and monitoring of cardiac dysfunction in survivors of adult cancers, originally published in the Journal of Clinical Oncology in March 2017.

Dr. Edward Balaban, medical director of the Cancer Care Partnership at Penn State Health, presents the ASCO Clinical Practice Guideline on locally advanced, unresectable pancreatic cancer, originally published in the Journal of Clinical Oncology in August 2016.